Human decay accelerating factor expressed on endothelial cells of transgenic pigs affects complement activation in an ex vivo liver perfusion model.
Pascher
A
A
Institute for Surgical Research, University of Munich, Germany.
Poehlein
C H
CH
Storck
M
M
Abendroth
D
D
Mueller-Hoecker
J
J
Young
V K
VK
Koenig
W
W
White
D J
DJ
Hammer
C
C
D000818:Animals; D030801:Animals, Genetically Modified; D018958:CD55 Antigens / Q000096:biosynthesis* / Q000235:genetics; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D015938:Complement Membrane Attack Complex / Q000032:analysis; D004730:Endothelium, Vascular / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000276:immunology / Q000502:physiology*; D010477:Perfusion; D013552:Swine
D018958:CD55 Antigens; D003176:Complement C3; D003181:Complement C4; D015938:Complement Membrane Attack Complex